Genetic engineering of biological systems is a fundamental tool for both basic and translation research, where up- and down-regulation of gene expression is necessary to drive cellular phenotypes and evaluate gene function.
The emergence of SARS-CoV-2 variants during the COVID-19 pandemic has demonstrated a need for broad immunization, such as provided by multivalent vaccines.
Researchers in the Appel lab have developed hydrogels for tumor inoculation that improve precision and statistical power in preclinical mouse models of cancer.
This invention is an intraoral palate expanding plate with an expansion screw for both cleft palate and restricted airways that can be produced by 3-D printing and CT scans.
A team of Stanford computer scientists have developed software that can serve as a key enabling technology for location-aware services indoors. Location-aware services are an important emerging technology for mobile devices.
Stanford inventor Dr. Anne Liu has developed an algorithm that can assess the risk of allergic reaction to antibiotics and help clinicians make decisions about which antibiotic to prescribe in patients who have a history of antibiotic allergies at the point-of-care.
Researchers at Stanford have developed a process for modifying metal powder stock to enable printing of high reflectivity metals using moderate laser powers (200-400 W) in commercially available printing systems (200-400W).
Researchers at Stanford have found that nascent polypeptide-associated complex (NAC) and the apical domain of CCT1, as well as peptide fragments and fusion proteins containing them, can be used to suppress pathological protein aggregation.
Stanford researchers have constructed a microbial cell factory by genetically modifying the bacterium Methylomicrobium alcaliphilum 20Z to convert methanol and methane into para-hydroxybenzoic acid (p-HBA).
Jennifer Cochran and Carolyn Bertozzi have collaborated to develop a bifunctional molecule called a polyspecific integrin-binding peptide (PIP)-LYTAC that can bind to integrins expressed on the surface of cancer cells and trigger their degradation via the lysosome.
Researchers at Stanford University have developed a deep learning software algorithm that allows physicians running clinical trials to predict control patient outcomes using virtual control arms.